Essential fatty acid metabolism and its modification in atopic eczema

American Journal of Clinical Nutrition

Volumn 71, Issue 1 SUPPL., 2000, Pages

  Horrobin, David F ^a  

^a Laxdale Ltd   (United Kingdom)

Author keywords

AA; Arachidonic acid; Atopic dermatitis; DGLA; Dihomo linolenic acid; Eczema; EFAs; Essential fatty acids; Evening primrose oil; GLA; Linoleic acid; linolenic acid

Indexed keywords

CATECHOLAMINE; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; LINOLEIC ACID; OMEGA 6 FATTY ACID; PRIMROSE OIL;

ATOPIC DERMATITIS; CONFERENCE PAPER; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; OUTCOMES RESEARCH; PATHOGENESIS; TREATMENT OUTCOME;

ANIMALIA; OENOTHERA; PRIMULA;

EID: 0033958250     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.1.367s     Document Type: Conference Paper

References (82)

1. Burr GO, Burr MM. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 1929;82:345-67.
2. Burr GO, Burr MM. On the nature and role of the fatty acids essential in nutrition. J Biol Chem 1930;86:587-621.
3. Sheretz EF. The skin and essential fatty acid deficiency. In: Roe DA, ed. Nutrition and the skin. New York: Alan R Liss, 1986:117-30.
4. Horrobin DF. Essential fatty acids in clinical dermatology. J Am Acad Dermatol 1989;20:1045-53.
5. Wright S. Essential fatty acids and the skin. Br J Dermatol 1991;125:503-15.
6. Burton JL. Dietary fatty acids and inflammatory skin disease. Lancet 1989;1:27-31.
7. Lowe NJ, DeQuoy PR. Linoleic acid effects on epidermal DNA synthesis and cutaneous prostaglandin levels in essential fatty acid deficiency. J Invest Dermatol 1978;70:200-3.
8. Basnayake V, Sinclair HM. Skin permeability in deficiency of essential fatty acids. J Physiol 1954;126:55P-6P.
9. Hartop PJ, Prottey C. Changes in transepidermal water loss and the composition of epidermal lecithin after applications of pure fatty acid triglycerides to skin of essential fatty acid-deficient rats. Br J Dermatol 1976;95:255-64.
10. Prottey C. Investigation of functions of essential fatty acids in the skin. Br J Dermatol 1977;97:29-38.
11. Ziboh VA. Biochemical abnormalities in essential fatty acid deficiency. Models Dermatol 1987;3:106-11.
12. Bowser PA, Nugteren DH, White RJ, Houtsmuller UM, Prottey C. Identification, isolation and characterization of epidermal lipids containing linoleic acid. Biochim Biophys Acta 1985;834:419-28.
13. Ziboh VA, Chapkin RS. Biologic significance of polyunsaturated fatty acids in the skin. Arch Dermatol 1987;123:1686A-90A.
14. Ziboh VA. Essential fatty acids/eicosanoid biosynthesis in the skin: biological significance. Proc Soc Exp Biol Med 1994;205:1-11.
15. Ziboh VA, Miller CC. Essential fatty acids and polyunsaturated fatty acids: significance in cutaneous biology. Annu Rev Nutr 1990;10: 433-50.
16. Nugteren DH, Christ-Hazelhof E, van der Beek A, Houtsmuller UM. Metabolism of linoleic acid and other essential fatty acids in the epidermis of the rat. Biochim Biophys Acta 1985;834:429-36.
17. Kassis V. The prostaglandin system in human skin. Dan Med Bull 1983;30:320-43.
18. Chapkin RS, Ziboh VA. Inability of skin enzyme preparations to biosynthesize arachidonic acid from linoleic acid. Biochem Biophys Res Commun 1984;124:784-92.
19. Chapkin RS, Ziboh VA, Marcelo CL, Voorhees JJ. Metabolism of essential fatty acids by human epidermal enzyme preparations: evidence of chain elongation. J Lipid Res 1986;27:945-54.
20. Hansen AE, Haggard ME, Boelesche AN, Adam D, Wiese HF. Essential fatty acids in infant nutrition III. Clinical manifestations of linoleic acid deficiency. J Nutr 1958;66:565-76.
21. Hansen AE, Wiese HF. Essential fatty acids and human nutrition II. Serum level for unsaturated fatty acids in poorly nourished infants and children. J Nutr 1954;52:367-74.
22. Hansen AE. Study of iodine number of serum fatty acids in infantile eczema. Proc Soc Exp Biol Med 1933;30:1198-9.
23. Brown WR, Hansen AE. Arachidonic acid and linoleic acid of the serum in normal and eczematous human subjects. Proc Soc Exp Biol Med 1937;36:113-6.
24. Faber HK, Roberts DB. Studies in infantile allergic eczema II. Serum lipids, with special reference to saturation of the fatty acids. J Pediatr 1933;3:490-3.
25. Hansen AE, Knott EM, Wiese HF, Shaperman E, McQuarrie I. Eczema and essential fatty acids. Am J Dis Child 1947;73:1-18.
26. Manku MS, Horrobin DF, Morse N, et al. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot Med 1982;9:615-28.
27. Manku MS, Horrobin DF, Morse NL, Wright S, Burton JL. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol 1984;110:643-8.
28. Strannegard IL, Svennerholm L, Strannegard O. Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical cord serum of infants with high or low IgE levels. Int Arch Allergy Appl Immunol 1987;82:422-3.
29. Wright S, Bolton C. Breast milk fatty acids in mothers of children with atopic eczema. Br J Nutr 1989;62:693-7.
30. Wright S, Sanders TA. Adipose tissue essential fatty acid composition in patients with atopic eczema. Eur J Clin Nutr 1991;45: 501-5.
31. Oliwiecki S, Burton JL, Elles K, Horrobin DF. Levels of essential and other fatty acids in plasma and red cell phospholipids from normal controls and patients with atopic eczema. Acta Derm Venereol 1991;71:224-8.
32. Biagi PL, Hrelia S, Celadon M, et al. Erythrocyte membrane fatty acid composition in children with atopic dermatitis compared to age-matched controls. Acta Paediatr 1993;82:789-90.
33. Yu G, Kjellman N-I, Bjorksten B. Phospholipid fatty acids in cord blood: family history and development of allergy. Acta Paediatr 1996;85:679-83.
34. Sakai K, Ueno K, Ogawa Y, Okuyama H. Fatty acid compositions of plasma lipids in young atopic patients. Chem Pharm Bull 1986;34: 2944-9.
35. Shimasaki H. PUFA content and effect of dietary intake of gamma-linolenic acid-rich oil on profiles of n-6, n-3 metabolites in plasma of children with atopic eczema. J Clin Biochem Nutr 1995;19:183-92.
36. Wright S. Atopic dermatitis and essential fatty acids: a biochemical basis for atopy? Acta Derm Venereol Suppl (Stockh) 1985;114:143-5.
37. Wright S. Essential fatty acids and atopic dermatitis. Pediatr Allergy Immunol 1991;2(suppl):23-30.
38. Melnik BC, Plewig G. Atopy: a prostaglandin E precursor- and receptor-dependent defect in T-cell maturation and function? Br J Dermatol 1990;123:126-8.
39. Melnik BC, Plewig G. Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1? J Am Acad Dermatol 1989;21:557-63.
40. Galli E, Picardo M, Chini L, et al. Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease? Br J Dermatol 1994;130:752-6.
41. Hansen AE. Serum lipids in eczema and other pathological conditions. Am J Dis Child 1937;53:933-46.
42. Taub SJ, Zakon SJ. The use of unsaturated fatty acids in the treatment of eczema. JAMA 1935;105:1675-85.
43. Epstein NN, Glick D. Unsaturated fatty acids in eczema. Observations on acne vulgaris, psoriasis, xanthoma tuberosum and xanthoma palpebrarum. Arch Dermatol 1937;35:427-32.
44. Ginsberg JE, Bernstein C, Iob LV. Effects of oils containing unsaturated fatty acids on patients with dermatitis. Arch Dermatol 1937;36:1033-8.
45. Hansen AE, Wiese HF, Boelsche AN, Haggard ME, Adam DJD, Davis H. Role of linoleic acid in infant nutrition. Clinical and chemical study of 428 infants fed on milk mixtures varying in kinds and amount fat. Pediatrics 1963;31:171-92.
46. Cornbleet T. Use of maize oil (unsaturated fatty acids) in the treatment of eczema. Arch Dermatol 1935;31:224-6.
47. Finnerud CW, Kesler RL, Wiese HF. Ingestion of lard in the treatment of eczema and allied dermatoses. Arch Dermatol 1941;44:849-61.
48. Pettit JHS. Use of unsaturated fatty acids in the eczemas of childhood. Br Med J 1954;1:79-81.
49. Schafer L, Kragballe K. Supplementation with evening primrose oil in atopic dermatitis: effect on fatty acids in neutrophils and epidermis. Lipids 1991;26:557-60.
50. Ziboh VA. Prostaglandins, leukotrienes, and hydroxy fatty acids in epidermis. Semin Dermatol 1992;11:114-20.
51. Ziboh VA. The significance of polyunsaturated fatty acids in cutaneous biology. Lipids 1996;31:249-53.
52. Chapkin RS, Ziboh VA, McCullough JL. Dietary influences of evening primrose and fish oil on the skin of essential fatty acid-deficient guinea pigs. J Nutr 1987;117:1360-70.
53. Ziboh VA. Implications of dietary oils and polyunsaturated fatty acids in the management of cutaneous disorders. Arch Dermatol 1989;125:241-5.
54. Courage B, Nissen HP, Wehrmann W, Biltz H. Influence of polyunsaturated fatty acids on the plasma catecholamines of patients with atopic eczema. Z Hautkr 1991;66:509-10 (in German).
55. Nissen HP, Wehrmann W, Kroll U, Kreysel HW. Influence of polyunsaturated fatty acids on the plasma phospholipids of atopic patients. Fat SCi Technol 1988;90:268-71.
56. Marshall RJ, Evans RW. Measurement of the effects of essential fatty acids on human skin smoothness. In: Horrobin DF, ed. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. New York: Alan R Liss, 1990:81-98.
57. Lovell CR, Burton JL, Horrobin DF. Treatment of atopic eczema with evening primrose oil. Lancet 1981;1:278 (letter).
58. Wright S, Burton JL. Oral evening-primrose-seed oil improves atopic eczema. Lancet 1982;2:1120-2.
59. Schalin-Karrila M, Manila L, Jansen CT, Uotila P. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. Br J Dermatol 1987;117:11-9.
60. Bordoni A, Biagi PL, Masi M, et al. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp Clin Res 1988;14:291-7.
61. Biagi PL, Bordoni A, Masi M, et al. A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs Exp Clin Res 1988;14:285-90.
62. Biagi PL, Bordoni A, Hrelia S, et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994;20:77-84.
63. Anstey A, Quigley M, Wilkinson JD. Topical evening primrose oil as treatment for atopic eczema. J Dermatol Treatment 1991;1:199-201.
64. Guenther L, Wexler D. Efamol in the treatment of atopic dermatitis. J Am Acad Dermatol 1987;17:860 (letter).
65. Meigel W. Treatment of atopic dermatitis. Z Hautkr 1985;61:473-8 (in German).
66. Humphreys F, Symons JA, Brown HK, Duff GN, Hunter JA. The effects of gamma-linolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur J Dermatol 1994;4:598-603.
67. Bamford JTM, Gibson RW, Renier CM. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). J Am Acad Dermatol 1985;13:959-65.
68. Berth-Jones J, Graham-Brown RAC. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557-60.
69. Horrobin DF, Stewart C. Evening primrose oil in atopic eczema. Lancet 1990;335:864-5.
70. Horrobin DF, Stewart C. Evening primrose oil and atopic eczema. Lancet 1990;336:50.
71. Horrobin DF, Morse PF. Evening primrose oil and atopic eczema. Lancet 1995;345:260-1.
72. Morse PF, Horrobin DF, Manku MS, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989;121:75-90.
73. Stewart JCM, Morse PF, Moss M, et al. Treatment of severe and moderately severe atopic dermatitis with evening primrose oil (Epogam): a multi-centre study. J Nutr Med 1991;2:9-15.
74. Wehrmann W, Niedecken H, Bauer R. Clinical and immunological effects of unsaturated fatty acids in patients with atopic eczema. Z Hautkr 1987;62(suppl):111-5 (in German).
75. Fiocchi A, Sala M, Signoroni P, Banderali G, Agostoni C, Riva E. The efficacy and safety of gamma-linolenic acid in the treatment of infantile atopic dermatitis. J Int Med Res 1994;22:24-32.
76. Hollmann J, Michelsen S, Jansen TH, Plewing G, Rippke F. Effect of high-dose oral therapy with evening primrose oil on the main lipid fractions in severe atopic dermatitis. H + G 1993 71:115-20.
77. Sugai T. Clinical evaluation of oral evening primrose oil in atopic patients. Skin Res 1987;29:330-8.
78. Wuthrich B. Neurodermitis. Schweiz Z Ganzheits Medizin 1995; 5:234-7.
79. Bjorneboe A, Soyland E, Bjorneboe GE, Rajka G, Drevon CA. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol 1987;117:463-9.
80. Soyland E, Rajka G, Bjorneboe A, Bjorneboe GE, Drevon CA. The effect of eicosapentaenoic acid in the treatment of atopic dermatitis. A clinical study. Acta Derm Venereol Suppl (Stockh) 1989;144:139 (abstr).
81. Balli F, Tarozzi G, Barzanti V, Di Biase AR, Bertolani P, Cocchi M. Combined use of omega 6 and omega 3 fatty acids in childhood atopic dermatitis (DA). Riv Ital Pediatr 1992;18:639-43 (in Italian).
82. Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol 1994;130:757-64.